Antigen presentation is a key rate-limiting step in the immune response. Dendritic cells (DC) are the most potent antigen-presenting cells for naive T cells, due to their high expression of MHC and co-stimulatory molecules, but little is known about the biochemical pathways that regulate this function. We here demonstrate that monocyte-derived mature DC can be infected with adenovirus at high efficiency (>95%) and that this procedure can be used to dissect out which pathways are essential for inducing DC antigen presentation to naive T cells. Using adenoviral transfer of the endogenous inhibitor of NF-κB, IκBα, we show that DC antigen presentation is NF-κB dependent. The mechanism for this is that NF-κB is essential for three aspects of antigen-presenting function: blocking NF-κB coordinately down-regulates HLA class II, co-stimulatory molecules like CD80, CD86 and CD40, and immuno-stimulatory cytokines like IL-12 and tumor necrosis factor-α. In contrast adhesion molecules are up-regulated after infection with the adenovirus transferring IκBα, indicating that NF-κB also regulates the duration of T cell-DC interaction. These results establish NF-κB as an effective target for blocking DC antigen presentation and inhibiting T cell-dependent immune responses, and this finding has potential implications for the development of therapeutic agents for use in allergy, autoimmunity and transplantation.
Introduction
Dendritic cells (DC) are the most effective cells for presentathe immune response, so evident in vitro, has been confirmed in vivo by the demonstration that blocking antigen presentation tion of antigen to naive T cells in the primary immune response (1). They are bone marrow-derived cells which were first down-regulates both humoral and cell-mediated immune responses, and has been shown to be useful in treating described in the early 1970s by Steinman and Cohn (2) , and subsequently studied by many groups, e.g. (3) (4) (5) (6) . Studies on animal models of disease. Thus antibody to murine MHC class II has been used to treat experimental allergic DC were initially hampered by the difficulty in isolating them in sufficient numbers from tissues or blood, but this problem encephalomyelitis (11) and blocking the CD80/86 co-stimulatory molecules with antibodies or CTLA-4-Ig fusion protein is was overcome in part by the realization that a subset of DC could be generated in vitro by culture of CD34 ϩ cells or human beneficial in transplants (12) or animal models of autoimmunity such as arthritis or encephalomyelitis (13, 14) . This has led to monocytes with granulocyte macrophage colony stimulating factor (GM-CSF) and IL-4 (7-9). These cultured DC have the a search of new ways of down-regulating antigen presentation which may be useful in human diseases or in transplantation. phenotype of immature DC, and can subsequently be matured into high MHC expressing, high CD80/86 expressing DC However, this work has been hampered by the lack of knowledge about the intracellular pathways that regulate through incubation with tumor necrosis factor (TNF)-α or lipopolysaccharide (LPS) (10) .
antigen presentation. Many, if not most, normal human cells transfect poorly with The importance of antigen presentation in the generation of the techniques available today such as electroporation or lipofection (15) , which work well with a restricted number of cell lines. Hence the powerful genetic approaches for analysing biochemical or cell signalling pathways, by introducing constructs expressing inhibitory or activating molecules cannot be used in normal cells (16) . In order to overcome this difficulty, we have developed methods of augmenting the efficiency of adenoviral uptake into various normal cells, including human macrophages, which has enabled us to demonstrate, for example, that cytokine (TNF-α) gene regulation is complex and stimulus dependent, even in a single cell type (17, 18) . Here we show that monocyte-derived mature DC can be infected with adenovirus at high efficiency (Ͼ95%) and that this procedure can be used to dissect out which pathways are essential for inducing dendritic antigen presentation to naive T cells. The results indicate that antigen presentation is dependent on NF-κB activation and that all three aspects of antigen-presenting function, i.e. MHC expression, co-stimulatory molecule expression and cytokine production, are coordinately regulated.
Methods

Reagents
Human recombinant GM-CSF and TNFα were kind gifts of Dr Glenn Larsen (GI) and Dr D. Tracey (BASF) respectively. Human recombinant IL-4 was purchased from R & D Systems (Minneapolis, MN). Phorbol myristate acetate (PMA) and LPS were obtained from Sigma (St Louis, MO). Soluble CD40 ligand-CD8 construct-producing cells J588L were generously provided by Dr P. Lane (Basel Institute for Immunology) and Dr A. Schimpl (Institute fü r Virologie und Immunbiologie). Supernatant from J588L was collected from confluent cultures and filtered (0.2 µm). 
Dendritic cell maturation
CD83 (PE-conjugated; Immunotech, Marseille, France), CD1b (PEconjugated; Serotec, Oxford, UK), CD40 (FITC-conjugated; PharMononuclear cells were isolated from single-donor plateMingen) and CD25 (PE-conjugated; PharMingen). Secondary letphoresis residues as described (17) . A total of 10 7 monoantibody was PE-conjugated F(abЈ) 2 goat anti mouse Ig (Southern cytes were plated in 10 ml volumes in 100 mm Petri dishes Biotechnology Associates). Cell populations cultured with (red line) or without (green line) DC maturation were phenotyped with the panel and DC maturation was performed as described (19 transferred to new Petri dishes. The cultures were supplemented with monocyte conditioned medium (MCM) (20) and TNF-α at final concentrations of 20% v/v and 10 ng/ml respectively. Fresh GM-CSF and IL-4 were present during all Analysis of infectibility the culture period. In some experiments, cells were washed Mature DC were re-plated on 96-well flat-bottom plate at a out of supplemental cytokines or MCM at day 6 or 9 before density of 2ϫ10 5 cells/well and were either left uninfected, or use in phenotypic or functional assays.
infected for 2 h with a m.o.i. of from 40:1 to 500:1 of Adv0 or AdvβGal, in serum-free RPMI 1640. Cells were then incubated Adenoviral vectors in RPMI 1640 supplemented as described above but without Recombinant, replication-deficient adenoviral vectors encod-MCM. Cells were taken off the plates 48 h after infection, ing Escherichia coli β-galactosidase (AdvβGal) or having no spun down, washed in FACS staining solution and incubated insert (Adv0) were provided by Drs A. Byrnes and M. Wood at 37°C for 10 min before 45 µl of a 2 mM solution of (Oxford, UK). An adenovirus encoding porcine IκBα with a fluorescein-di-(β-D)-galactopyranoside (Sigma) was added for CMV promoter and a nuclear localization sequence (AdvIκBα) 1 min (23). Addition of excess (10 times) ice-cold staining was provided by Dr R. de Martin (Vienna, Austria). Viruses solution was used to stop the reaction and cell fluorescence was analysed by FACS as described below. were propagated and titred as previously described (21, 22) . 
Flow cytometry analysis of DC infectibility and surface markers
Western blotting, and the p42/p44 MAP kinases were used as a control (B) and nuclear extracts were analysed for NF-κB activity by All samples were analysed on a FACScan flow cytometer electrophoretic mobility shift assay (C).
using the CellQuest software (Becton Dickinson, San Jose, CA). Analysis was carried out on a population of cells gated by forward and side scatter to exclude dead cells and debris. Dendritic cell surface markers were studied using mAb to: Western blotting and electrophoretic mobility shift assay HLA-DR, CD86, CD11c, CD14 [phycoerythrin (PE)-conjugBatches of 10ϫ10 6 DC were either left uninfected, infected ated; PharMingen, San Diego, CA), CD83 (PE-conjugated; with 300:1 of Adv0 or infected with 300:1 of AdvIκBα. Two Immunotech, Marseille, France), CD1b (PE-conjugated; Serodays after infection cells were either left unstimulated or tec, Oxford, UK), CD40 (FITC-conjugated; PharMingen) and stimulated with LPS (50 ng/ml) for 60 min. Cytosolic and CD25 (PE-conjugated; PharMingen), HLA-DQ (FITC-conjugnuclear extracts were prepared as described (24) and ated; PharMingen), CD80 (PE-conjugated; PharMingen), proteins separated by SDS-PAGE on a 10% (w/v) poly-CD54 (PE-conjugated; Serotec), CD50 and CD11a acrylamide gel, followed by electrotransfer onto nitrocellulose (FITC-conjugated; Serotec). Secondary antibody, used when membranes. IκBα and the p42/p44 MAP kinases were appropriate, was PE-conjugated F(ab') 2 goat anti-mouse Ig detected using antibodies purchased from Santa Cruz Bio-(Southern Biotechnology Associates, Oxford, UK). technology (Santa Cruz, CA).
Analysis of apoptosis Protein (20 µg) from the nuclear extracts prepared as described above was analysed for NF-κB activity by electroMature DC were left uninfected, infected with 300:1 Adv0 or phoretic mobility shift assay as previously described (23).
infected with 300:1 AdvIκBα as described above. Cells were Competition analysis with excess cold NF-κB probe and with then cultured in complete medium for 2 days prior to being an unrelated probe (AP-1) was performed.
transferred to a 50 µg/ml solution of propidium iodide (29) and kept on ice for 30 min before analysis by FACS scan to Analysis of cytokines monitor DNA fragmentation. In these experiments, mature DC were either left uninfected, Statistical methods or infected with a m.o.i. of 300:1 of Adv0 or AdvIκBα as described above. Cells were then incubated in RPMI 1640
All statistical testing was performed using a paired comparison, one-sided Student's t-test. supplemented as described above, but without MCM. Two 
Results
regulated by AdvIκBα (Fig. 4) , indicating their dependence on NF-κB. The production of other cytokines, including IL-8,
Infectivity of DC by adenovirus and reduction in cytokine
IL-15, IL-18 and the p75 soluble TNF receptor, were either production by adenovirus overexpressing inhibitor of NF-κB unchanged or less potently affected by NF-κB inhibition ( Table  1 ), indicating that these cytokines were chiefly regulated by Several groups have previously demonstrated that DC can be infected by adenovirus (30-32), in order to help induce other pathways. There was no detectable production of certain anti-inflammatory cytokines, e.g. IL-10 or the IL-1 receptor immune responses to a variety of genes. However, they have not described infection efficiencies that were high enough antagonist in these cultures (data not shown). (Ͼ90%) to efficiently block pathways and permit assessment Reduction in antigen-presenting function by inhibiting NF-κB of the importance of these pathways in DC function. DC were derived from monocytes purified by centrifugal elutriation, by
As the culture period for generating DC in vitro is relatively long and requires significant quantities of human blood, it culture with GM-CSF and IL-4 for 6 days as described by Sallusto and Lanzavecchia (7). For maturation, TNF-α and was more feasible to initially study the antigen-presenting function of DC by using the mixed lymphocyte reaction. This MCM were added for 3 days (19, 20) . Figure 1 documents the phenotype of the in vitro generated mature DC: high DR, uses allogeneic cells, from two different blood donors, rather than repeatedly employing the same donor, as is needed CD83, CD1b, CD40, CD11c, CD86 and CD25; low CD14. The infectivity of mature DC was assessed using an adenovirus for antigen-specific T cell responses. DC have long been acknowledged to be the most potent antigen-presenting cells encoding β-galactosidase (Advβgal) and was Ͼ95% at a m.o.i. of 300:1 (Fig. 2A) , but not at lower virus titres. Infection for the mixed lymphocyte (33) . As few as 100 DC clearly induce a proliferative response, assayed by the uptake of of mature DC with 300:1 was routinely performed with an adenovirus encoding IκBα (AdvIκBα). This leads to abundant non-radioactive BrdU or [ 3 H]thymidine (Fig. 5) . There was no effect of infecting DC with Adv0, but AdvIκBα infection cytosolic overexpression of IκBα, while infection with an adenovirus with no insert had no effect (Fig. 2B ). An electrodramatically reduced T cell proliferation, as was consistently observed in six experiments using BrdU or three with [ 3 H]thyphoretic mobility shift assay demonstrated that AdvIκBα infection inhibits LPS-induced NF-κB activation (Fig. 2C) ; midine to assay proliferation (Fig. 5) . The effect of AdvIκBα on peptide-specific antigen presentation was also assessed. competition experiments using excess cold NF-κB probe and using an unrelated probe were performed to ascertain that Preliminary data indicate that antigen presentation to longterm tetanus toxoid T cell lines is also markedly inhibited by the shifted band seen was really active NF-κB. To rule out that this IκBα overexpression caused DC apoptosis, a DNA AdvIκBα infection (V. Calder et al., unpublished data). fragmentation assay was performed as described in Methods.
Mechanism of reduced antigen-presenting function There was no increase in DC apoptosis caused either by adenovirus infection per se or by NF-κB inhibition (Fig. 3) .
We have analysed the molecular mechanism by which AdvIκBα inhibits DC antigen-presenting function. The fact This enabled us to ascertain the effect of blocking NF-κB on DC function. First, we studied the production of some key that AdvIκBα infection reduces the production of several proinflammatory cytokines made it relevant to investigate the proinflammatory DC cytokines, induced by various stimuli, PMA, LPS and CD40 ligand. TNF-α induced by PMA, IL-6 role of these molecules in the reduced antigen-presenting capacity and experiments adding back IL-12, IL-15 or TNF-α induced by PMA or LPS and IL-12 (p70) induced by PMA or soluble CD40 ligand were significantly (P Ͻ 0.001) downto IκBα-inhibited DC were performed. The AdvIκBα-inhibited Upper part: effect of adenovirus infection on the production of various pro-inflammatory and anti-inflammatory cytokines induced by different stimuli (mean ϮSEM; n ϭ 7 for IL-8, n ϭ elsewhere). sCD40L, CD40 ligand.
Lower part: mean expression of various surface markers in uninfected and adenovirus-infected DC (mean ϮSEM; n ϭ 3 for ICAMs and LFA-1, n ϭ 6 elsewhere). Fig. 6 . Effect of neutralizing antibodies on the immuno-stimulatory capacity of mature DC. Graded numbers of mature DC and 10 5 cells of allo-lymphocytes were plated in 96-well plates. Then neutralizing antibodies were added to each well: control Ig (µg/ml) (s), anti-TNF-α antibody (0.1 µg/ml) (d), anti-IL-12 antibody (0.5 µg/ml) (m), anti-CD86 antibody (1 µg/ml) (j) and anti-CD86 antibody (0.1 µg/ml) (u). Proliferation was determined at day 6 using the BrdU assay. Each point represents mean Ϯ SEM from three separate experiments. DC (Fig. 6 ) and so reduction in these stimulatory cytokines Fig. 7 . The effect of AdvIκBα infection on DC surface markers was studied using mAb to some of the antigens listed in the legend to Fig. 1 , and also HLA-DQ (FITC-conjugated; PharMingen), CD80 (PE-conjugated; PharMingen), CD54 (PE-conjugated; Serotec), CD50 and CD11a (FITC-conjugated; Serotec). On day 5 after infection, populations of uninfected (green line), 300:1 Adv0-infected (solid black line) and 300:1 AdvIκBα-infected (dotted black line) DC were phenotyped with the panel of mAb listed above and compared with isotype control (blue area) analysed on a FACS scan (Becton Dickinson).
probably contributes in part towards the reduced antigenthat it is the combined reductions in multiple aspects of antigen presentation, i.e. antigen (DR, DQ) expression, copresenting capacity after AdvIκBα infection.
In the investigation of the mechanism of the dramatic effect stimulatory molecules and cytokines that leads to the observed marked inhibition of antigen presentation after AdvIκBα of NF-κB blockade on DC antigen presentation, changes in cell-surface antigens were also investigated. It was noteworthy infection. that some cell surface markers, like ICAM-1, LFA-1 and especially ICAM-3, which are involved in adhesion of T Discussion lymphocytes to DC were up-regulated after AdvIκBα infection, while multiple others involved in antigen presentation, includ-
The data presented here demonstrates unequivocally that NF-κB is a major regulator of the antigen-presenting function ing HLA-DR, HLA-DQ, CD86, CD80 and CD40 were downregulated ( Fig. 7 and Table 1) .
of mature DC. This possibility had been suggested previously by the presence of activated NF-κB in the nucleus of mature It is likely that the largest single molecular mechanism contributing to the inhibited antigen-presenting cell function DC (35) , but this correlation did not constitute proof of the essential role of NF-κB in this process nor did studies with may be reduced co-stimulation, as judged by the profound inhibitory effect on the mixed lymphocyte reaction of antiRelB knockouts, which have no DC of myeloid type (36). Only with the development of an efficient and specific inhibitory CD86 antibody (34) , which mimicked that of AdvIκBα (Fig.  6) . However, diluting the levels of anti CD86 antibody 10-fold method as described in this manuscript can the role of NF-κB be established. We have substantiated the results obtained reduced the inhibitory effect markedly (Fig. 6) , making it likely with AdvIκBα using an alternative inhibitor of NF-κB, proteofunction remains to be evaluated. There is now evidence for heterogeneity of DC in both mouse and human systems some inhibitor I [Cbz-Ile-Glu(O-t-bu)-Ala-leucinal], which inhibits NF-κB activation by preventing the degradation of (50, 51) . Whether NF-κB is also essential for the antigenpresenting function of the other subset in man or the three IκBα by the proteosome (37,38): in a dose-dependent manner, this drug inhibited the antigen presentation of DC in the mixed subsets in mouse remains to be established. The coordinate regulation of multiple aspects of antigenlymphocyte reaction (39).
The variable effects of AdvIκBα on cell-surface molecules presenting function by NF-κB is one of the striking observations of this study, with three major functions, i.e. MHC class was of interest (Fig. 7) . These results clearly demonstrate, as do more direct tests (Fig. 3) , that the effect of AdvIκBα is not II expression, co-stimulation and certain cytokines diminishing if NF-κB is inhibited by AdvIκBα. In contrast, adherence non-specifically 'toxic' and does not induce apoptosis. NF-κB inhibition has been shown to induce apoptosis in a variety of molecules (LFA-1, ICAM-1 and ICAM-3) were augmented by AdvIκBα indicating that in the normal NF-κB regulation of cell lines (40) (41) (42) but not in primary non-cycling macrophages (17) . The diminution of CD86, CD80 and CD40 are all likely antigen-presenting function, limiting adhesion is probably also important, to permit antigen-presenting cells to detach and to be important in the reduction in antigen-presenting function, but the exact contribution of each of them is difficult to so be able to activate multiple T cells (52). Limiting T cell-DC contact may also be important in favoring immunity rather disentangle; the profound effect of antibodies to CD86 would indicate that this molecule is of considerable importance than immunological tolerance. The work described here has multiple scientific and medical (Fig. 6) .
In contrast there was up-regulation of ICAM-1, LFA-1 and implications. Defining therapeutic targets is very important in the long process of developing new therapeutic agents, as it ICAM-3 by IκBα. These proteins are involved in the clustering of T cells with antigen-presenting cells (43) (44) (45) , and this result focuses future research and development into the areas most likely to be productive. NF-κB appears to be such a target suggests that the physical interaction of T cells and DC and their attachment is also influenced by NF-κB, but in the for blocking antigen presentation, whose inhibition would be useful in various medical conditions, such as in transplantaopposite way. The phenomenon that inhibition of NF-κB can result in up-regulation of some molecules, while others are tion, allergy and autoimmunity. In terms of gene therapy, AdvIκBα or other viruses engineered to block antigen predown-regulated, has earlier been observed in c-rel -/-macrophages (46) . It was of interest that certain cytokines produced sentation are likely to inhibit the immune response to the adenovirus itself and so could prolong the expression of by DC (e.g. TNF-α, IL-6 and IL-12) were regulated by NF-κB, but that others (e.g. IL-8, IL-15 and IL-18) were not. This desired genes by the virus in vivo. In scientific terms, the results described here are also of importance. It has been suggests that other pathways are also involved in regulating this aspect of antigen presentation. In this context it would proposed by Janeway and others (53,54) that activation of the innate immune system is a key component of immune be interesting to evaluate the effects of NF-κB inhibition on DC chemokines and their receptors (47) , which would influinduction. Graphically this has been termed the 'danger signal' that activates the immune response (53,55). Our ence the selective migration of T cells and DC and their potential interaction. studies suggest that this 'danger signal' operates via the activation of NF-κB. The capacity of AdvIκBα to block antigen presentation by 99% (Fig. 5) suggests that the efficiency of adenoviral infection (Fig. 2 ) in these studies was very high. This is because of the sensitivity of the functional antigen presentation assay, which Acknowledgements would detect as few as 100 functioning DC in 10,000, i.e. This work was supported by the Arthritis Research Campaign and Ͻ1% (Fig. 5) The new technique described here has provided the first direct evidence that the pathways regulating antigen presentation can be analysed and that NF-κB is essential for References antigen presentation. The effects of blocking single subunits of NF-κB can be addressed using adenoviruses. Whether
